WASHINGTON (Reuters) – The U.S. purchased 200 million more doses of the Pfizer/BioNTech vaccine for flexibility if booster shots are later needed and the shots are approved for younger children, the White House said on Friday.
The vaccine makers announced the government’s purchase earlier on Friday.
(Reporting by Jeff Mason and Trevor Hunnicutt; Editing by Chris Reese)
